Remove Development Remove Finance Remove Pharmaceuticals Remove Process
article thumbnail

How Big Data Brings Marketing and Finance Together

Harvard Business Review

Rajamannar involved finance early. To spearhead analytic efforts, he assigned a finance person – who was already embedded in marketing – to create an ROI evaluation framework and integrated her deeper into the marketing function. MasterCard had always been a data-driven organization. Inside Intel. The result has been transformational.

Finance 11
article thumbnail

Performance Measurement

Strategy Driven

Value: The Four Cornerstones of Corporate Finance by Tim Koller. While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Discusses the four foundational principles of corporate finance.

ROIC 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51
article thumbnail

Health Care Is an Investment, and the U.S. Should Start Treating It Like One

Harvard Business Review

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations.

article thumbnail

Using Games to Get a Handle on Bank Risk

Harvard Business Review

Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10
article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Executive teams need to assess their industries’ and companies’ time horizons for the technology, because they will have a huge amount of strategic and business process planning to do before their companies adopt it.

article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Roivant’s first response was to address misaligned incentives.